Ihab Michel Wahba, MD
Professor of Clinical Medicine (Renal-Electrolyte and Hypertension)
Chief, Section of Nephrology, Philadelphia VA Medical Center
Medical Director, Outpatient Dialysis, Philadelphia VA Medical Center
Medical Director, Inpatient Dialysis, Philadelphia VA Medical Center
Director, Resistant Hypertension Clinic, Philadelphia VA Medical Center
Co-Chair, VISN4 Dialysis Council, CMCVAMC Philadelphia
VISN4 Nephrology Subspecialty Lead , CMCVAMC Philadelphia
Department: Medicine
Contact information
VAMC
3900 Woodland Ave
Philadelphia, PA 19104
3900 Woodland Ave
Philadelphia, PA 19104
Office: 215-662-7934
Links
Philadelphia Corporal Michael J. Crescenz VA Medical Center
Penn's Renal-Electrolyte and Hypertension Division
Philadelphia Corporal Michael J. Crescenz VA Medical Center
Penn's Renal-Electrolyte and Hypertension Division
Education:
M.B.B.Ch.
Cairo University, 1991.
Permanent linkM.B.B.Ch.
Cairo University, 1991.
Description of Clinical Expertise
Cardiorenal syndromeResistant hypertension
Disorders of water balance (Sodium disorders)
Acid-base disorders
Drug nephrotoxicity
Drug dosing in CKD and ESRD
Dialysis care
Gadolinium and kidney disease
Nephrogenic systemic fibrosis
Description of Other Expertise
Teaching medical students, residents and fellowsDescription of Research Expertise
Drug dosing in dialysisDrug nephrotoxicity
Cardiorenal syndrome
Intra-abdominal hypertension
Obesity and renal disease
Acute kidney injury
Resistant hypertension
Selected Publications
Wahba IM: Gadolinium and kidney disease: Should we still be cautious? Clin J Am Soc Nephrol 2025.Pennekamp A, Wahba I: Importance of MAP reduction for AKI induction in type 1 cardiorenal syndrome. Am J Kidney Dis 2023 Notes: In Press.
Rudnick MR, Fay K, Wahba IM: Fluid administration strategies for the prevention of contrast-associated acute kidney injury. Curr Opin Nephrol Hypertens 31(5): 414-424, September 2022.
Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI: Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis 4: 517-528, 2021.
Rudnick M, Wahba IM, Miskulin D: Nephrogenic systemic fibrosis/nephrogenic fibrosing dermopathy in advanced kidney disease. UpToDate April 2020- Current.
Srinivasan V, Ahmad S, Aggarwal S, Wahba I, Huan Y: COVID-19 infection patterns in an academic inner city dialysis unit. Journal of the American Society of Nephrology October 2020.
Rudnick M, Wahba IM, Leonberg-Yoo A: Use of Gadolinium-Based Contrast Agents in Patients with Severe Renal Impairment. Absence of Risk Versus Caution: A Nephrologist’s Perspective. Kidney360 1(6): 433-435, June 2020.
Fink JC, Joy MS, St Peter WL, Wahba IM; ASN Chronic Kidney Disease Advisory Group.: Finding a common language for patient safety in CKD. Clin J Am Soc Nephrol 7(4): 689-95, Apr 2012 Notes: doi: 10.2215/CJN.12781211.
Dadfarmay S, Wahba IM : Acute kidney injury due to pulmonary embolism: The case for congestive kidney failure. Nephrol Dial Transplant Plus 4: 295-298, 2011.
Wahba IM: The renal consequences of obesity- What have we learned in recent years? US Nephrology 3(2): 12-15, 2009.